| Reducing Target Volumes in NPC Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy (NCT04384627) | Sun Yat-sen University | 2019-12-01 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
| Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC (NCT04220528) | Fujian Cancer Hospital | 2019-12-01 |
| Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma (NCT04472403) | Sun Yat-sen University | 2019-11-26 |
| Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma (NCT04764149) | Sun Yat-sen University | 2019-11-01 |
| De-escalation Protocols in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT04158518) | Chaosu Hu | 2019-11-01 |
| A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients (NCT04061278) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-08-01 |
| The Prognostic Value of Human Papilloma Virus in Nasopharyngeal Carcinoma (NCT04014738) | Rambam Health Care Campus | 2019-07-20 |
| Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC (NCT04015661) | Fuzhou General Hospital | 2019-07-09 |
| Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (NCT03923842) | Gruppo Oncologico del Nord-Ovest | 2019-06-30 |
| Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma. (NCT04073784) | Sun Yat-sen University | 2019-06-08 |
| Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma (NCT03932266) | Jiangsu Cancer Institute & Hospital | 2019-06-01 |
| Prospective Comparisons of Clinical Trial and Real-world Outcomes in Nasopharyngeal Carcinoma (NCT04108338) | Sun Yat-sen University | 2019-06-01 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma Patients (NCT03855020) | Sun Yat-sen University | 2019-05-09 |
| Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA (NCT03544099) | National Health Research Institutes, Taiwan | 2019-05-07 |
| Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. (NCT03891953) | Novartis Pharmaceuticals | 2019-05-07 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. (NCT03854838) | Sun Yat-sen University | 2019-05-01 |
| Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy (NCT03906058) | Sun Yat-sen University | 2019-04-29 |
| Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma (NCT04528394) | Shanghai Proton and Heavy Ion Center | 2019-04-29 |
| Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma (NCT03837808) | Sun Yat-sen University | 2019-04-11 |
| Phase 1/2a Study of VK-2019 in Patients With Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma (NPC) (NCT03682055) | Cullinan Therapeutics Inc. | 2019-04-04 |
| GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03840421) | Sun Yat-sen University | 2019-04-03 |
| Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma (NCT04398056) | Sun Yat-sen University | 2019-04-01 |
| Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT04004871) | Guangxi Medical University | 2019-03-28 |
| A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma (NCT03866967) | Akeso | 2019-03-27 |
| KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT03848286) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2019-03-06 |
| Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer (NCT03809624) | Inhibrx Biosciences, Inc | 2019-01-30 |
| Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis (NCT03788499) | Xinqiao Hospital of Chongqing | 2019-01-11 |
| The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma (NCT06268600) | Jiangxi Provincial Cancer Hospital | 2019-01-01 |
| Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis (NCT03904225) | Zhejiang Cancer Hospital | 2018-12-14 |
| Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT03707509) | Jiangsu HengRui Medicine Co., Ltd. | 2018-11-13 |
| Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma (NCT03668730) | Sun Yat-sen University | 2018-10-19 |
| Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT03708822) | Sun Yat-sen University | 2018-10-15 |
| EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC (NCT03648697) | Fujian Cancer Hospital | 2018-10-10 |
| Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma (NCT04522050) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2018-10-01 |
| Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC (NCT03601390) | Sun Yat-sen University | 2018-10-01 |
| Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis (NCT03720340) | Zhejiang Cancer Hospital | 2018-10-01 |
| Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma (NCT03601975) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-08-27 |
| SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. (NCT03558191) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-14 |
| Intestinal Flora Sequencing for Nasopharyngeal Carcinoma (NCT04094545) | The Third Xiangya Hospital of Central South University | 2018-08-01 |
| PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial (NCT05520814) | Sichuan Cancer Hospital and Research Institute | 2018-08-01 |
| To Investigate the Molecular Mechanism of Traditional Chinese Medicine Constitution Using Next-generation Sequencing in Nasopharyngeal Carcinoma (NCT03578575) | China Medical University Hospital | 2018-07-26 |
| Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma (NCT03598218) | Wei Jiang | 2018-07-13 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma (NCT03612219) | Wei Jiang | 2018-07-01 |
| Radiation-associated Carotid Artery Disease in Patients With Nasopharyngeal Carcinoma (NCT03568032) | Fudan University | 2018-07-01 |
| TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients (NCT03588403) | Zhejiang Cancer Hospital | 2018-07-01 |
| CNG Staging Compared With 8th UICC of NPC for Treatment Decision-marking and Selection of Chemotherapy and Radiotherapy (NCT03529279) | Sun Yat-sen University | 2018-06-12 |
| Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous Chemotherapy (NCT03390738) | The University of Hong Kong | 2018-06-01 |
| PET/MR in Locally Advanced Nasopharyngeal Carcinoma (NCT03657017) | Zhejiang Cancer Hospital | 2018-06-01 |
| By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC (NCT03557112) | Guiyang Medical University | 2018-06-01 |
| Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (NCT03503136) | Sun Yat-sen University | 2018-06-01 |
| Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma (NCT03701451) | Wei Jiang | 2018-02-28 |
| Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) (NCT03267498) | Sue Yom | 2018-02-14 |
| Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy (NCT05020067) | Sun Yat-sen University | 2018-01-12 |
| Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC (NCT03366415) | Chaosu Hu | 2018-01-01 |
| Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma (NCT03344068) | Sun Yat-sen University | 2018-01-01 |
| Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients (NCT03411954) | Zhejiang Cancer Hospital | 2018-01-01 |
| Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients (NCT03290820) | Sun Yat-sen University | 2018-01-01 |
| Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 Stage (NCT03403829) | Fudan University | 2018-01-01 |
| To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma (NCT03346109) | Sun Yat-sen University | 2017-11-16 |
| TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma (NCT03306121) | Sun Yat-sen University | 2017-11-13 |
| Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma (NCT03321539) | Sun Yat-sen University | 2017-10-30 |
| Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients (NCT03353467) | Sun Yat-sen University | 2017-10-01 |
| The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients (NCT03240835) | Zhao Chong | 2017-09-12 |
| The Influence of Anxiety and Depression on Survival in Nasopharyngeal Carcinoma Patients (NCT03290001) | Sun Yat-sen University | 2017-08-20 |
| Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (NCT03213587) | Zhejiang Cancer Hospital | 2017-07-01 |
| 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study (NCT04995185) | National Cancer Centre, Singapore | 2017-06-20 |
| A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects (NCT03121716) | Jiangsu HengRui Medicine Co., Ltd. | 2017-04-26 |
| Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma (NCT03087695) | Taichung Veterans General Hospital | 2017-04-01 |
| Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma (NCT03097939) | National Cancer Centre, Singapore | 2017-03-31 |
| Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03025958) | Zhejiang Cancer Hospital | 2017-03-13 |
| IMRT Plus Cisplatin Versus IMRT in Patients With Stage 2 Nasopharyngeal Carcinoma (NCT03068936) | Nanfang Hospital, Southern Medical University | 2017-03-01 |
| Study of DC-CTL Combined With CIK for Advanced Solid Tumor (NCT03047525) | Xiaoyi Huang | 2017-02-20 |
| Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma (NCT02698111) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2017-02-08 |
| Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03047265) | Sun Yat-sen University | 2017-02-04 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients (NCT03942380) | Christian von Buchwald | 2017-02-01 |
| Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue (NCT03048305) | Sun Yat-sen University | 2017-02-01 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma (NCT03130270) | Guilin Medical University, China | 2017-01-01 |
| Prospective Study for Prognostic Biomarkers of Nasopharyngeal Carcinoma (NCT03025854) | Sun Yat-sen University | 2017-01-01 |
| The Diagnosis of NPC Using the Probe-based Confocal Laser Endomicroscopy (NCT03202173) | Eye & ENT Hospital of Fudan University | 2017-01-01 |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis (NCT02022293) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2017-01-01 |
| PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma (NCT03989297) | Kiang Wu Hospital | 2017-01-01 |
| Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03058432) | Zhejiang Cancer Hospital | 2017-01-01 |
| Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03020329) | Sun Yat-sen University | 2016-11-14 |
| TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma (NCT02940925) | Sun Yat-sen University | 2016-10-20 |
| Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02907710) | First Affiliated Hospital of Guangxi Medical University | 2016-10-01 |
| Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy (NCT03398980) | Yuan-hong Gao | 2016-09-02 |
| Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy (NCT03647527) | Zhejiang Cancer Hospital | 2016-09-01 |
| Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02871518) | Sun Yat-sen University | 2016-08-01 |
| A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. (NCT02878889) | Zhejiang Cancer Hospital | 2016-08-01 |
| Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT02505672) | Rabin Medical Center | 2016-08-01 |
| Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients (NCT02854410) | Capital Medical University | 2016-08-01 |
| Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02786641) | Sun Yat-sen University | 2016-08-01 |
| Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy (NCT03045484) | Sun Yat-sen University | 2016-05-01 |
| Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma (NCT02761291) | Chang Gung Memorial Hospital | 2016-05-01 |
| Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT02605967) | Novartis Pharmaceuticals | 2016-04-20 |